×
Organigram Holdings Price to Free Cash Flow Ratio 2019-2024 | OGI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Organigram Holdings price to free cash flow ratio from 2019 to 2024. Price to free cash flow ratio can be defined as
View More
Organigram Holdings Price to Free Cash Flow Ratio 2019-2024 | OGI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Organigram Holdings price to free cash flow ratio from 2019 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$200B
Stryker (SYK)
$141B
Boston Scientific (BSX)
$128B
Medtronic (MDT)
$113B
EssilorLuxottica (ESLOY)
$112.7B
Lonza Group Ag (LZAGY)
$45.3B
Haleon (HLN)
$43.5B
GE HealthCare Technologies (GEHC)
$40.4B
ResMed (RMD)
$36.5B
Terumo (TRUMY)
$30.3B
Koninklijke Philips (PHG)
$25.9B
Zimmer Biomet Holdings (ZBH)
$21.6B
Baxter (BAX)
$18.4B
Insulet (PODD)
$17.2B
Smith & Nephew SNATS (SNN)
$10.8B
Bio-Rad Laboratories (BIO)
$10.4B
BellRing Brands (BRBR)
$8.9B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$6.1B
Haemonetics (HAE)
$4.4B
ICU Medical (ICUI)
$4.4B
TG Therapeutics (TGTX)
$4.3B
Prestige Consumer Healthcare (PBH)
$4B
Envista Holdings (NVST)
$3.7B
Perrigo (PRGO)
$3.7B
Neogen (NEOG)
$3.4B
Agios Pharmaceuticals (AGIO)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.6B